Cargando…
The role of (m)SEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer
BACKGROUND: The application of circulating, cell-free, methylated Septin9 ((m)SEPT9) DNA in screening and recurrence monitoring is highly promising. CpG island methylator phenotype (CIMP) is associated with microsatellite instability (MSI). The present study was performed to determine the diagnostic...
Autores principales: | Sun, Jie, Fei, Fei, Zhang, Mingqing, Li, Yuwei, Zhang, Xipeng, Zhu, Siwei, Zhang, Shiwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518628/ https://www.ncbi.nlm.nih.gov/pubmed/31088406 http://dx.doi.org/10.1186/s12885-019-5663-8 |
Ejemplares similares
-
Plasma-Methylated SEPT9 for the Noninvasive Diagnosis of Gastric Cancer
por: Zhao, Luyao, et al.
Publicado: (2022) -
Daughter Cells and Erythroid Cells Budding from PGCCs and Their Clinicopathological Significances in Colorectal Cancer
por: Zhang, Dan, et al.
Publicado: (2017) -
Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer
por: Fu, Bo, et al.
Publicado: (2018) -
Screening and Prognostic Value of Methylated Septin9 and its Association With Clinicopathological and Molecular Characteristics in Colorectal Cancer
por: Sun, Jie, et al.
Publicado: (2021) -
Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study
por: Zhang, Mingqing, et al.
Publicado: (2022)